A µ-opioid receptor superagonist analgesic with minimal adverse effects

Binding screen

These experiments were performed by a commercial vendor (Eurofins) under contract with the National Institutes of Health (NIH). Membrane homogenates from stable cell lines or animal tissues expressing each protein were incubated…

Continue Reading


News Source: www.nature.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *